Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents: A Feasibility Study
Catheter occlusion and dysfunction are common complications of central venous access device (CVAD) use in children with cancer and hematologic disorders. These events can lead to interruption of therapy and may require device removal and replacement. Attempts to clear occlusion can cause device fracture.
There is a clear link between catheter occlusion and other serious complications including bloodstream infection and intravascular thrombosis.
There is evidence that catheter occlusion or dysfunction may be preceded by subclinical catheter narrowing, which could be detected by accurate measurement of catheter resistance.
This study aims to observe and describe the feasibility and results of catheter resistance monitoring (CRM) over time with the aim of prospectively identifying patients at high risk of catheter occlusion.
If CRM is feasible and proves to be sensitive and specific, it could provide an opportunity for preemptive therapy to prevent occlusion, which might also prevent bloodstream infection or thrombosis.
調査の概要
詳細な説明
Weekly measurement of catheter resistance will be determined using the Alaris® Syringe Module (Carefusion Inc., San Diego, USA), a commercially available, FDA-approved intravenous (IV) pump which is able to deliver accurate flow-rates and obtain accurate pressure measurements. The inline pressure will be measured at multiple flow-rates and resistance will be estimated from the gradient of the pressure-flow curve.
Primary Objective
- To describe the feasibility of weekly CRM in children and adolescents treated at St. Jude.
Secondary Objectives
- To describe patient and caregiver adherence with weekly CRM in children and adolescents treated at St. Jude.
- To explore the correlation between results of CRM and catheter occlusion or dysfunction.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Tennessee
-
Memphis、Tennessee、アメリカ、38105
- St. Jude Children's Research Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Receiving treatment for any disease at St. Jude Children's Research Hospital (SJCRH).
- Age ≥5 years to <25 years.
- Participant is using either a single or double lumen tunneled CVAD (ports will not be eligible) as part of standard clinical care.
- Participant anticipates being present weekly at SJCRH for at least 12 weeks
Exclusion Criteria:
- Plan to remove CVAD within 12 weeks.
- Expected survival less than 12 weeks
- Past enrollment in the CaRMA study or past catheter resistance monitoring
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
---|---|
Participants
Participants include children with cancer and hematologic disorders who, as part of their standard clinical care, have a central venous access device (CVAD) used for infusion, withdrawal of blood, or hemodynamic monitoring. Intervention: Catheter resistance monitoring |
Weekly measurement of resistance to flow in the lumen(s) of a CVAD with the commercially available Alaris® Syringe Module IV pump.
The aim is to identify an increase in resistance greater than normal variation.
Inline pressure measurements will be recorded at multiple flow-rates and resistance will be estimated from the gradient of the pressure-flow curve.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Proportion of attended CRM visits which produce usable resistance data for all lumens of the CVAD
時間枠:Weekly for 12 weeks from study entry or until discontinuation of CRM, whichever is shorter
|
To describe the feasibility of CRM in children and adolescents treated at St. Jude, the proportion of attended CRM visits which produce usable resistance data for all lumens of the CVAD will be recorded for each participant, and summary statistics, including median, range and standard deviation will be reported for the study population.
|
Weekly for 12 weeks from study entry or until discontinuation of CRM, whichever is shorter
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Attendance at each planned CRM visit
時間枠:Weekly for 12 weeks or until discontinuation of CRM for a prescribed reason, whichever is shorter
|
To describe patient and caregiver adherence with weekly CRM in children and adolescents treated at St. Jude, attendance at each planned CRM visit will be recorded.
Summary statistics for proportion of planned visits attended for each participant, including median, range and standard deviation will be reported for the study population.
|
Weekly for 12 weeks or until discontinuation of CRM for a prescribed reason, whichever is shorter
|
The relationship between CRM results and occlusion or dysfunction
時間枠:Up to 15 weeks
|
To explore the correlation between the results of CRM and catheter occlusion or dysfunction in children and adolescents, the relationship between CRM results and occlusion or dysfunction will be described.
|
Up to 15 weeks
|
協力者と研究者
捜査官
- 主任研究者:Joshua Wolf, MBBS、St. Jude Children's Research Hospital
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
癌の臨床試験
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight Therapeutics積極的、募集していない平滑筋肉腫 | 悪性末梢神経鞘腫瘍 | 滑膜肉腫 | 未分化多形肉腫 | 骨の未分化高悪性度多形肉腫 | 粘液線維肉腫 | II期の体幹および四肢の軟部肉腫 AJCC v8 | III期の体幹および四肢の軟部肉腫 AJCC v8 | IIIA 期の体幹および四肢の軟部肉腫 AJCC v8 | IIIB 期の体幹および四肢の軟部肉腫 AJCC v8 | 切除可能な軟部肉腫 | 多形性横紋筋肉腫 | 切除可能な脱分化型脂肪肉腫 | 切除可能な未分化多形肉腫 | 軟部組織線維肉腫 | 紡錘細胞肉腫 | ステージ I 後腹膜肉腫 AJCC (American Joint Committee on Cancer) v8 | 体幹および四肢の I 期軟部肉腫 AJCC v8 | ステージ... およびその他の条件アメリカ
Catheter Resistance Monitoringの臨床試験
-
Boston Scientific Corporation完了
-
BrosMed Medical Co., LtdCCRF Inc., Beijing, Chinaわからない
-
Royal Brompton & Harefield NHS Foundation TrustUniversity of Oxford; National Institute for Health Research, United Kingdom完了
-
Universidade Metodista de Piracicaba完了アスレチックパフォーマンス | アスリート | 呼吸筋 | 呼吸法 | 有酸素容量